An Oncology Product Manager plays a pivotal role in the development, positioning, and lifecycle management of oncology-focused pharmaceutical or diagnostic products. This professional bridges the gap between science, business, and clinical needs—working closely with cross-functional teams including R&D, regulatory affairs, marketing, and medical affairs. Their responsibilities typically include developing go-to-market strategies, defining product messaging, analyzing market trends, and supporting sales teams with the tools and insights needed to effectively promote cancer therapies or diagnostic solutions. A deep understanding of oncology markets, competitive landscapes, and clinical data is essential to ensuring that products meet the complex needs of healthcare providers and patients alike.
In both pharmaceutical and biotech settings, Oncology Product Managers are also responsible for gathering customer feedback, supporting clinical trial integration, and aligning product goals with unmet medical needs. They may collaborate with key opinion leaders (KOLs), attend scientific conferences, and manage product launch timelines to maximize impact and adoption. With oncology evolving rapidly through innovations in immunotherapy, targeted therapy, and diagnostics, the role of the product manager is more strategic than ever. Their ability to translate complex scientific insights into meaningful product value helps drive innovation forward—ultimately contributing to more effective treatments, improved patient outcomes, and commercial success in a highly competitive industry.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China